SCOPUS 정보 검색 플랫폼

Volumn 107, Issue 3, 2016, Pages 264-266

Pembrolizumab: A new Drug That Can Induce Exacerbations of Psoriasis;Pembrolizumab, un nuevo fármaco capaz de inducir un brote psoriasis

(4) Sahuquillo Torralba, A a Ballester Sanchez R a Pujol Marco, C a Botella Estrada, R a

a HOSPITAL UNIVERSITARIO LA FE (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEMBROLIZUMAB; ETRETIN;

DISEASE EXACERBATION; HUMAN; LETTER; PSORIASIS; AGED; ARTICLE; CASE REPORT; CLINICAL ARTICLE; DETERIORATION; DISEASE SEVERITY; DRUG DOSE INCREASE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALE; PSORIASIS AREA AND SEVERITY INDEX; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84953231244 PISSN: 00017310 EISSN: 15782190 Source Type: Journal
DOI: 10.1016/j.ad.2015.07.012 Document Type: Article

Times cited : (28)

References (9)

1
- 84858766182
- The blockade of immune checkpoints in cancer immunotherapy
- D.M. Pardoll The blockade of immune checkpoints in cancer immunotherapy Nat Rev Cancer 12 2012 252 264
- (2012) Nat Rev Cancer , vol.12 , pp. 252-264
- Pardoll, D.M.¹

2
- 84890980389
- Breathing new life into immunotherapy: Review of melanoma, lung and kidney cancer
- C.G. Drake, E.J. Lipson, and J.R. Brahmer Breathing new life into immunotherapy: Review of melanoma, lung and kidney cancer Nat Rev Clin Oncol 11 2014 24 37
- (2014) Nat Rev Clin Oncol , vol.11 , pp. 24-37
- Drake, C.G.¹ Lipson, E.J.² Brahmer, J.R.³

3
- 84862882003
- Tumor immunotherapy directed at PD-1
- A. Ribas Tumor immunotherapy directed at PD-1 N Engl J Med 366 2012 2517 2519
- (2012) N Engl J Med , vol.366 , pp. 2517-2519
- Ribas, A.¹

4
- 84937252297
- Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis
- M. Peled, M. Strazza, I. Azoulay-Alfaguter, and A. Mor Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis Inflammation 38 2015 1580
- (2015) Inflammation , vol.38 , pp. 1580
- Peled, M.¹ Strazza, M.² Azoulay-Alfaguter, I.³ Mor, A.⁴

5
- 84900199200
- Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis
- S. Li, W. Liao, M. Chen, S. Shan, Y. Song, S. Zhang, and et al. Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis Inflammation 3 2014 116 121
- (2014) Inflammation , vol.3 , pp. 116-121
- Li, S.¹ Liao, W.² Chen, M.³ Shan, S.⁴ Song, Y.⁵ Zhang, S.⁶

6
- 84864052441
- Management of immune-related adverse events and kinetics of response with ipilimumab
- J.S. Weber, K.C. Kahler, and A. Hauschild Management of immune-related adverse events and kinetics of response with ipilimumab J Clin Oncol 30 2012 2691 2697
- (2012) J Clin Oncol , vol.30 , pp. 2691-2697
- Weber, J.S.¹ Kahler, K.C.² Hauschild, A.³

7
- 84890288009
- Immune-mediated adverse events associated with ipilimumab CTLA-4 blockade therapy: The underlying mechanisms and clinical management
- Tarhini A. Immune-mediated adverse events associated with ipilimumab CTLA-4 blockade therapy: The underlying mechanisms and clinical management. Scientifica (Cairo). 2013;2013:857519.
- (2013) Scientifica (Cairo) , vol.2013 , pp. 857519
- Tarhini, A.¹

8
- 84925379870
- Identification and management of toxicities from immune checkpoint-blocking drugs
- B.A. Teply, and E.J. Lipson Identification and management of toxicities from immune checkpoint-blocking drugs Oncology (Williston Park) 28 Suppl 3 2014 S30 38
- (2014) Oncology (Williston Park) , vol.28 , pp. S30-38
- Teply, B.A.¹ Lipson, E.J.²

9
- 84862903106
- Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
- J.R. Brahmer, S.S. Tykodi, L.Q. Chow, W.J. Hwu, S.L. Topalian, and P. Hwu Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N Engl J Med 366 2012 2455 2465
- (2012) N Engl J Med , vol.366 , pp. 2455-2465
- Brahmer, J.R.¹ Tykodi, S.S.² Chow, L.Q.³ Hwu, W.J.⁴ Topalian, S.L.⁵ Hwu, P.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.